StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE

Investment analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Price Performance Can-Fite BioPharma stock opened at $2.09 on Tuesday. Can-Fite BioPharma has a one year low of $1.76 and […]

Related Keywords

Fite Biopharma , Schechter Investment Advisors , Exchange Commission , Fite Biopharma Ltd , Fite Biopharma Company Profile , Can Fite Biopharma , Get Free Report , Investment Advisors , Free Report , Can Fite Biopharma Daily , Nyse Canf , Ocanf , Medical , Initiated Coverage , Stocknews Com ,